Literature DB >> 23558624

Blocking bleeding: reversing anticoagulant therapy.

Jack Ansell.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23558624     DOI： 10.1038/nm.3157

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  Emergency hospitalizations for adverse drug events in older Americans.

Authors:  Daniel S Budnitz; Maribeth C Lovegrove; Nadine Shehab; Chesley L Richards
Journal:  N Engl J Med       Date:  2011-11-24       Impact factor: 91.245

2.  Reverse engineering for new oral anticoagulants: non-specific reversal agents and the anticoagulant activity of dabigatran and rivaroxaban.

Authors:  M Levi
Journal:  Thromb Haemost       Date:  2012-06-28       Impact factor: 5.249

Review 3.  Reversal of antithrombotic agents.

Authors:  Kenneth A Bauer
Journal:  Am J Hematol       Date:  2012-03-28       Impact factor: 10.047

Review 4.  Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.

Authors:  Scott Kaatz; Peter A Kouides; David A Garcia; Alex C Spyropolous; Mark Crowther; Jim D Douketis; Anthony K C Chan; Andra James; Stephan Moll; Thomas L Ortel; Elizabeth M Van Cott; Jack Ansell
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

5.  Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran.

Authors:  Sarah T Garber; Walavan Sivakumar; Richard H Schmidt
Journal:  J Neurosurg       Date:  2012-03-06       Impact factor: 5.115

Review 6.  Oral anticoagulant therapy--50 years later.

Authors:  J E Ansell
Journal:  Arch Intern Med       Date:  1993-03-08

7.  Antidote-mediated control of an anticoagulant aptamer in vivo.

Authors:  Christopher P Rusconi; Joseph D Roberts; George A Pitoc; Shahid M Nimjee; Rebekah R White; George Quick; Elizabeth Scardino; William P Fay; Bruce A Sullenger
Journal:  Nat Biotechnol       Date:  2004-10-17       Impact factor: 54.908

8.  A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.

Authors:  Genmin Lu; Francis R DeGuzman; Stanley J Hollenbach; Mark J Karbarz; Keith Abe; Gail Lee; Peng Luan; Athiwat Hutchaleelaha; Mayuko Inagaki; Pamela B Conley; David R Phillips; Uma Sinha
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440
  8 in total
  4 in total

Review 1.  Oral anticoagulants for Asian patients with atrial fibrillation.

Authors:  Ian Sabir; Kaivan Khavandi; Jack Brownrigg; A John Camm
Journal:  Nat Rev Cardiol       Date:  2014-03-11       Impact factor: 32.419

2.  Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban.

Authors:  Jack E Ansell; Sasha H Bakhru; Bryan E Laulicht; Solomon S Steiner; Michael A Grosso; Karen Brown; Victor Dishy; Hans J Lanz; Michele F Mercuri; Robert J Noveck; James C Costin
Journal:  Thromb Haemost       Date:  2016-11-17       Impact factor: 5.249

Review 3.  Management of bleeding in patients treated with direct oral anticoagulants.

Authors:  Marcel Levi
Journal:  Crit Care       Date:  2016-08-20       Impact factor: 9.097

Review 4.  Decision-Making Process for the Management of Acute Stroke in Patients on Oral Anticoagulant: From Guidelines to Clinical Routine.

Authors:  Igor Sibon; Mikael Mazighi; Didier Smadja
Journal:  Front Neurol       Date:  2022-01-05       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.